Skin testing for biologic drug allergies
Part of Blood & lymphatic, Cancer, Digestive system, Heart & circulation, Hormones & metabolism, Immune system & allergy, Lungs & breathing clinical trials.
This trial checks if people can safely receive certain biologic drugs without allergic reactions, using skin tests to see how the body reacts. It may help find out if you are allergic to a biologic medicine you have taken before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were treated with one of the study drugs (like Atezolizumab, Nivolumab, or Pembrolizumab) and have had at least two doses without any allergic reaction.
- You have health insurance or are covered by medical care assurance.
- You have given written permission to join the study.
- If you take steroids or allergy pills, you need to stop them for at least one week before the skin tests (using inhaled steroids is okay).
- You do not have any skin rashes or conditions like psoriasis or eczema that could affect the test results.
- You are not pregnant, breastfeeding, in detention, or under legal protection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well immunotherapy might work by analyzing fresh tumor biopsies. It may help predict which treatments are best for your cancer.
This trial tests a tiny device placed directly into skin lymphoma spots to help identify which “candidate” drugs could work. It’s mainly aimed at people with measurable skin involvement from T-cell lymphoma, after they stop certain treatments for a set time.
This study looks at a simple blood test to see if it can predict how well your cancer will respond to immunotherapy. You will give blood samples before and during treatment, and the researchers will analyze small particles in your blood to find clues about your likely response.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This study looks at blood samples from people with blood cancers to find markers that might predict how well immunotherapy will work. The goal is to help doctors choose the right treatment for each person.
This study checks how your immune system behaves (through an immune testing process) to see if it can predict how well advanced melanoma will respond to checkpoint inhibitor treatment. It may help doctors choose the right treatment sooner, without guessing.
Hear when a new Pleural Mesothelioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.